Company: CERO
Filing Date: 2025-11-20
Form Type: 424B3
Source: 0001213900-25-113118
Chunk: 10

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-11-20
Form: 424B3
Chunk 10
---
 shares of Legacy CERo preferred stock.

“Merger Sub” refers
to PBCE Merger Sub, Inc., a Delaware corporation.

“Nasdaq”
refers to the Nasdaq Stock Market LLC.

“November 2024 Keystone Purchase Agreement” refers to the Common Stock Purchase Agreement, dated as of November 8, 2024, by and between
CERo and Keystone.

“PBAX”
refers to Phoenix Biotech Acquisition Corp., a Delaware corporation.

“PIPE Financings”
refers to the First PIPE Financing, the Second PIPE Financing, the Third PIPE Financing, the Fourth PIPE Financing and the Fifth PIPE
Financing.

“Preferred Shares”
refer to the shares of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series
E Preferred Stock issued in the PIPE Financings, including the Warrant Preferred Shares.

“Preferred Warrants”
refer to warrants to purchase shares of Series A Preferred Stock.

“Primary Earnout Shares”
refer to the 600 shares of Common Stock issued to the holders of Legacy CERo common stock and Legacy CERo preferred stock in connection
with the Business Combination, 500 of which are subject to vesting upon the achievement of certain stock price-based earnout targets and
100 of which are subject to vesting upon a change of control, respectively.

<div align='center'>vi</div>

“Private Placement Warrants”
refer to private placement warrants to purchase shares of Common Stock, at an exercise price of $23,000.00 per share, that were originally
sold in a private placement concurrently with the Initial Public Offering.

“Public Warrants”
refer to the warrants to purchase shares of Common Stock, at an exercise price of $23,000.00 per share, that were originally issued in
the Initial Public Offering.

“Reverse Stock Splits”
refers to the Company’s reverse stock split that became effective at 12:01 a.m. Eastern time on January 8, 2025, pursuant to which
each 100 shares of Common Stock outstanding immediately prior thereto was converted into 1 share of Common Stock outstanding immediately
thereafter, and to the Company’s reverse stock split that became effective at 12:01 a.m. Eastern time on June 13, 2025, pursuant
to which each 20 shares of Common Stock outstanding immediately prior thereto was converted into 1 share of Common Stock outstanding immediately
thereafter.

“SEC” refers to